We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+9.7%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$27.3B
AUM Growth
+$2.26B
(+9%)
Cap. Flow
+$202M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
24.36%
Holding
1,897
New
97
Increased
682
Reduced
737
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$28.3M |
| 2 |
Allstate
ALL
|
+$25.8M |
| 3 |
Intuitive Surgical
ISRG
|
+$19.6M |
| 4 |
Neogen
NEOG
|
+$17.4M |
| 5 |
DoubleVerify
DV
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$29.1M |
| 2 |
Planet Fitness
PLNT
|
+$20.4M |
| 3 |
Airbnb
ABNB
|
+$17.1M |
| 4 |
IBM
IBM
|
+$14.8M |
| 5 |
Xometry
XMTR
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.59% |
| 2 | Healthcare | 18.44% |
| 3 | Industrials | 11.64% |
| 4 | Financials | 11.51% |
| 5 | Consumer Discretionary | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Silicon Laboratories
SLAB
$7.28B
| $538K | ﹤0.01% |
3,413
+1,000
| +41% | +$151K |
|
1027
Dick's Sporting Goods
DKS
$18.1B
| $536K | ﹤0.01% |
4,051
+338
| +9% | +$46.2K |
|
1028
iShares US Financials ETF
IYF
$4.44B
| $535K | ﹤0.01% |
7,165
+2,002
| +39% | +$144K |
|
1029
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7B
| $534K | ﹤0.01% |
13,333
-1,705
| -11% | -$70.4K |
|
1030
SentinelOne
S
$8.17B
| $533K | ﹤0.01% |
35,277
+21,390
| +154% | +$362K |
|
|
VSTO
1031
DELISTED
Vista Outdoor Inc.
VSTO
| $532K | ﹤0.01% |
19,240
-3,663
| -16% | -$99.1K |
|
1032
Ventas
VTR
$46.3B
| $531K | ﹤0.01% |
11,238
-2,348
| -17% | -$106K |
|
1033
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
| $528K | ﹤0.01% |
21,429
-10
| -0% | -$244 |
|
|
BELFB
1034
Bel Fuse Inc Class B
BELFB
$4.13B
| $525K | ﹤0.01% |
9,150
| – | – |
|
1035
Greif
GEF
$5.03B
| $523K | ﹤0.01% |
7,592
| – | – |
|
1036
Globus Medical
GMED
$11.5B
| $520K | ﹤0.01% |
8,736
+651
| +8% | +$37.1K |
|
1037
CBRE Group
CBRE
$44B
| $520K | ﹤0.01% |
6,440
-1,642
| -20% | -$123K |
|
1038
Boston Scientific
BSX
$74.9B
| $520K | ﹤0.01% |
9,609
-95
| -1% | -$4.96K |
|
1039
Genpact
G
$5.78B
| $519K | ﹤0.01% |
13,809
-8,449
| -38% | -$340K |
|
1040
Adaptive Biotechnologies
ADPT
$3.89B
| $517K | ﹤0.01% |
77,064
-1,800
| -2% | -$13.4K |
|
1041
OneSpaWorld
OSW
$2.73B
| $516K | ﹤0.01% |
42,665
+590
| +1% | +$6.82K |
|
1042
Sonos
SONO
$1.96B
| $516K | ﹤0.01% |
31,585
-1,526
| -5% | -$27.1K |
|
1043
Equinor
EQNR
$96.3B
| $515K | ﹤0.01% |
17,644
-669
| -4% | -$19.1K |
|
1044
iShares Core MSCI Europe ETF
IEUR
$9.15B
| $514K | ﹤0.01% |
9,774
+75
| +0.8% | +$3.99K |
|
1045
Vanguard FTSE Pacific ETF
VPL
$8.65B
| $511K | ﹤0.01% |
7,327
| – | – |
|
1046
Kemper
KMPR
$1.59B
| $511K | ﹤0.01% |
10,581
-400
| -4% | -$19.4K |
|
|
DEN
1047
DELISTED
Denbury Inc.
DEN
| $509K | ﹤0.01% |
5,901
| – | – |
|
1048
iShares Future Exponential Technologies ETF
XT
$4.01B
| $503K | ﹤0.01% |
9,055
| – | – |
|
1049
Arrowhead Research
ARWR
$12.1B
| $501K | ﹤0.01% |
14,040
-450
| -3% | -$15.5K |
|
1050
Procore
PCOR
$9.45B
| $496K | ﹤0.01% |
7,621
+3,555
| +87% | +$209K |
|
Similar funds
HF
William Blair & Company's Q2 2023 Portfolio in Review
As of Q2 2023, William Blair & Company held 1,897 positions worth $27.3B, up 9% from $25B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
William Blair & Company's Q2 2023 filing shows 97 new, 682 increased, 737 reduced and 88 closed positions. Its largest new stake was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M. The largest sale was Neurocrine Biosciences, an estimated $29.1M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- William Blair & Company's largest Q2 2023 buy was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M.
- William Blair & Company added most to Costco in Q2 2023, an estimated $28.3M increase.
- William Blair & Company's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $29.1M.
- William Blair & Company fully exited ABB Ltd in Q2 2023, selling an estimated $7.21M.
- William Blair & Company's ten largest holdings make up 24% of its $27.3B portfolio in Q2 2023.
- William Blair & Company opened 97 new positions and closed 88 in Q2 2023.
- William Blair & Company's portfolio value rose 9% quarter-over-quarter to $27.3B.
Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.